GL1X · GenesisL1 explorer

MolNFT v1 · #93187 · protein

Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor ME0355

4GV0 · Poly [ADP-ribose] polymerase 3: “Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor ME0355”. X-ray diffraction, 1 ligand (8ME), 2 pockets (best druggability 0.74). MolNFT v1 #93187 on GenesisL1: 3D structure, binding…

PDB
4GV0
Type
protein
Length
354 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 3
EC
2.4.2.30
UniProt
Q9Y6F1
Ligands
8ME
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 3 (EC 2.4.2.30)protein35436% helix, 24% strandQ9Y6F1

Ligands and binding sites

  • 8ME · 3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-[(1S)-1-(pyridin-2-yl)ethyl]propanamide · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14520.740.83468ME, DMS
2860.330.7419empty

Compared structures

  • 4GV0 · Human ARTD3 (PARP3) - Catalytic domain in complex with inhibitor ME0355 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y6F1 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP3 (Q9Y6F1) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.